These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 4408108

  • 1. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J, Papeschi R, Herz A.
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract] [Full Text] [Related]

  • 2. Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
    Herz A, Bläsig J, Papeschi R.
    Psychopharmacologia; 1974 Jul; 39(2):121-43. PubMed ID: 4476079
    [No Abstract] [Full Text] [Related]

  • 3. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF, Brase DA, Loh HH.
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the development of morphine dependence and morphine tolerance in rats].
    Theiss P, Herz A, Bläsig J.
    Arzneimittelforschung; 1974 Jul; 24(7):1014-5. PubMed ID: 4408044
    [No Abstract] [Full Text] [Related]

  • 5. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM, Babbini M, Khalsa HJ.
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract] [Full Text] [Related]

  • 6. [Neurobiologic aspects of the morphine addictions].
    Herz A, Bläsig J.
    Naturwissenschaften; 1974 Jun; 61(6):223-8. PubMed ID: 4603708
    [No Abstract] [Full Text] [Related]

  • 7. [Problems in quantification of provoked morphine withdrawal in rats].
    Herz A, Bläsig J.
    Arzneimittelforschung; 1974 Jul; 24(7):1012-4. PubMed ID: 4408092
    [No Abstract] [Full Text] [Related]

  • 8. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
    Mattila MJ, Alhava E, Mansner R.
    Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
    [No Abstract] [Full Text] [Related]

  • 9. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
    Papeschi R, Randrup A.
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
    [No Abstract] [Full Text] [Related]

  • 10. The role of dopamine and norepinephrine in the naloxone-induced abstinence of morphine-dependent mice.
    Maruyama Y, Takemori AE.
    J Pharmacol Exp Ther; 1973 Jun; 185(3):602-8. PubMed ID: 4736512
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin and dopamine turnover after acute and chronic morphine administration.
    Papeschi R, Theiss P, Herz A.
    Arzneimittelforschung; 1974 Jul; 24(7):1017-9. PubMed ID: 4408355
    [No Abstract] [Full Text] [Related]

  • 12. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA, Moore KE.
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract] [Full Text] [Related]

  • 13. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
    Thoa NB, Eichelman B, Ng LK.
    Brain Res; 1972 Aug 25; 43(2):467-75. PubMed ID: 5066136
    [No Abstract] [Full Text] [Related]

  • 14. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH, Davis WM.
    J Pharmacol Exp Ther; 1977 Jul 25; 202(1):182-91. PubMed ID: 17725
    [No Abstract] [Full Text] [Related]

  • 15. Effects of lithium on behaviour and central monoamines.
    Engel J, Berggren U.
    Acta Psychiatr Scand Suppl; 1980 Jul 25; 280():133-43. PubMed ID: 6773300
    [No Abstract] [Full Text] [Related]

  • 16. Brain catecholamine metabolites and behavior in morphine withdrawal.
    Swann AC, Elsworth JD, Charney DS, Jablons DM, Roth RH, Redmond DE, Maas JW.
    Eur J Pharmacol; 1982 Dec 24; 86(2):167-75. PubMed ID: 6297931
    [Abstract] [Full Text] [Related]

  • 17. Narcotic antagonists as stimulants of behavior in the rat: specific and nonspecific effects.
    Holtzman SG.
    Adv Biochem Psychopharmacol; 1973 Dec 24; 8(0):371-82. PubMed ID: 4794990
    [No Abstract] [Full Text] [Related]

  • 18. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG, Jewett RE.
    J Pharmacol Exp Ther; 1972 May 24; 181(2):346-56. PubMed ID: 5030675
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC, Miya TS, Blake DE, Bousquet WF.
    J Pharmacol Exp Ther; 1972 Jun 24; 181(3):446-56. PubMed ID: 5033011
    [No Abstract] [Full Text] [Related]

  • 20. Effects of depletion of brain catecholamines during the development of morphine dependence on precipitated withdrawal in rats.
    Bläsig J, Herz A, Gramsch C.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Jun 24; 286(4):325-36. PubMed ID: 238137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.